Everpar Advisors LLC Sells 300 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Everpar Advisors LLC trimmed its position in The Cooper Companies, Inc. (NASDAQ:COO) by 3.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 8,053 shares of the medical device company’s stock after selling 300 shares during the period. Everpar Advisors LLC’s holdings in Cooper Companies were worth $740,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies during the 3rd quarter valued at $25,000. Covestor Ltd lifted its holdings in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. boosted its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC bought a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $49,000. Finally, Friedenthal Financial purchased a new stake in shares of Cooper Companies during the 3rd quarter valued at approximately $50,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.5 %

Shares of COO opened at $92.04 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The firm has a market cap of $18.37 billion, a price-to-earnings ratio of 47.20, a PEG ratio of 2.29 and a beta of 0.99. The firm has a 50 day moving average price of $96.75 and a 200-day moving average price of $98.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm posted $0.87 earnings per share. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Wells Fargo & Company boosted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.